Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease
2011
Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart Failure
2011
Predictive Effects of Circulating miR-221, miR-130a and miR-155 for Coronary Heart Disease: A Multi-Ethnic Study in China.
2017 Standout
Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
2010
Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology
2015 Standout
Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)
2014 Standout
High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery
2013
Patients with Acute Coronary Syndrome and Normal High-sensitivity Troponin
2011
Universal Definition of Myocardial Infarction: Clinical Insights
2015 Standout
Towards better clinical prediction models: seven steps for development and an ABCD for validation
2014 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
A proteomic atlas of senescence-associated secretomes for aging biomarker development
2020 Standout
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
Increasingly Sensitive Assays for Cardiac Troponins
2013
Vagus-Dependent and Vagus-Independent Mechanisms of Action of the Erythromycin Derivative EM574 and Motilin in Dogs
1996 StandoutNobel
Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism
2010
Cardiac troponin I levels in patients with non–ST-elevation acute coronary syndrome—The importance of gender
2014
Antithrombotic Therapy for VTE Disease
2016 Standout
Cisapride
1994
Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section
2012
Six-Minute Walk Test as a Prognostic Tool in Stable Coronary Heart Disease
2012
Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays
2011
The GRACE score's performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide
2011
Systemic sclerosis
2017 Standout
Biomarkers of Chronic Cardiac Injury and Hemodynamic Stress Identify a Malignant Phenotype of Left Ventricular Hypertrophy in the General Population
2012
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
2020 Standout
Systematic review: sphincter of Oddi dysfunction – non‐invasive diagnostic methods and long‐term outcome after endoscopic sphincterotomy
2006
Cardiac troponin level elevations not related to acute coronary syndromes
2013
Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome
2010
Antithrombotic Therapy for VTE Disease
2012 Standout
How to use high-sensitivity cardiac troponins in acute cardiac care
2012
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Myocardial Ischemia Induced by Rapid Atrial Pacing Causes Troponin T Release Detectable by a Highly Sensitive Assay
2011
Clearance of cardiac troponin T with and without kidney function
2017
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle-aged men without overt cardiovascular disease
2010
Systemic amyloidosis
2015 Standout
Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population
2010
High-sensitive troponin T measurements: what do we gain and what are the challenges?
2012
One-Hour Rule-out and Rule-in of Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T
2012
Atherosclerosis
2019 Standout
Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery
2012
Third Universal Definition of Myocardial Infarction
2012 Standout
Cardiovascular biomarkers and sex: the case for women
2015
Introduction of High-sensitivity Troponin Assays: Impact on Myocardial Infarction Incidence and Prognosis
2012
Differential expression proteomics of human colon cancer
2006
Consideration of a New Definition of Clinically Relevant Myocardial Infarction After Coronary Revascularization
2013
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Prevalence and significance of troponin elevations in patients without acute coronary disease
2016
Determinants of High-Sensitivity Troponin T Among Patients with a Noncardiac Cause of Chest Pain
2012
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Periprocedural Myocardial Infarction
2010
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Universal amplification-free molecular diagnostics by billion-fold hierarchical nanofluidic concentration
2019
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
2016 Standout
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Heart Failure, Chronic Kidney Disease, and Biomarkers - An Integrated Viewpoint -
2010
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
High-Sensitivity Cardiac Troponin T for Early Prediction of Evolving Non–ST-Segment Elevation Myocardial Infarction in Patients with Suspected Acute Coronary Syndrome and Negative Troponin Results on Admission
2010
Unstable Angina
2013
Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay
2010
Association of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study
2011
Global Coronary Flow Reserve Is Associated With Adverse Cardiovascular Events Independently of Luminal Angiographic Severity and Modifies the Effect of Early Revascularization
2014
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Troponin I Measured by a High-Sensitivity Assay in Patients with Suspected Reversible Myocardial Ischemia: Data from the Akershus Cardiac Examination (ACE) 1 Study
2012
An Updated Definition of Stroke for the 21st Century
2013 Standout
Biological Variation and Reference Change Value of High-Sensitivity Troponin T in Healthy Individuals during Short and Intermediate Follow-up Periods
2011
Reshaping de Novo Protein Switches into Bioresponsive Materials for Biomarker, Toxin, and Viral Detection
2022 StandoutNobel
Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study
2011
High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation
2013
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Biomarkers of Cardiovascular Stress and Incident Chronic Kidney Disease
2013
High-Sensitivity Cardiac Troponin I Measurement for Risk Stratification in a Stable High-Risk Population
2011
Net Reclassification Improvement: Computation, Interpretation, and Controversies
2014
Use of Circulating MicroRNAs to Diagnose Acute Myocardial Infarction
2012
Cardiac Biomarkers in Systemic Sclerosis: Contribution of High‐Sensitivity Cardiac Troponin in Addition to N‐Terminal Pro‐Brain Natriuretic Peptide
2015
ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation
2012
Works of Solve Tjora being referenced
Enzymatic characteristics of tubular adenomas and carcinomas of the large intestine.
1982
Effect of Cisapride on Symptoms and Biliary D in Patients with Postcholecystectomy Syndrome
1991
Determinants and prognostic implications of Cardiac Troponin T measured by a sensitive assay in Type 2 Diabetes Mellitus
2010
A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease
2009
Sphincter of Oddi Dysfunction: Dynamic Cholescintigraphy and Endoscopic Retrograde Cholangiopancreatography with Papillotomy in Diagnosis, Treatment, and Follow-up Study
1989